Latest filing published 05 Jan 2023 for G1 Therapeutics, Inc..
Insider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Jennifer K. Moses: trading record in brief
Jennifer K. Moses is a declared insider of G1 Therapeutics, Inc., with filings sourced from SEC (Form 4). Over a trading history stretching from 5 January 2018 to 5 January 2023, the count stands at 39 filings.
No open-market purchase appears, only 15 sales worth €324k. The rest of the record consists of 3 share grants and 21 option exercises. Since January 2023: no purchases and 2 sales on the market.
The latest filing, published on 5 January 2023, reports an open-market sale of €8,671 in G1 Therapeutics, Inc. Filings reach the SEC (Form 4) feed a median of 1 day after the trade. US insiders must file a Form 4 within two business days of a trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Jennifer K. Moses
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 22,300 shares0Common StockSEC:0001562180-23-000255:0
- 333 shares@ US$3.72100.0% of flowCommon StockSEC:0001562180-22-000956:0
- 12,000 shares0Common StockSEC:0001562180-22-000306:0
3 of 3 declarations